3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
2
Active not recruiting
2
Withdrawn
1
Suspended
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Melanoma
91
Carcinoma, Non-Small-Cell Lung
84
Neoplasms
48
Carcinoma, Renal Cell
44
Neoplasm Metastasis
40
Carcinoma, Hepatocellular
36
Squamous Cell Carcinoma of Head and Neck
35
Colorectal Neoplasms
31
Pancreatic Neoplasms
24
Lung Neoplasms
20
Stomach Neoplasms
19
Head and Neck Neoplasms
18
Carcinoma, Transitional Cell
17
Hodgkin Disease
16
Breast Neoplasms
16
Small Cell Lung Carcinoma
15
Ovarian Neoplasms
14
Urinary Bladder Neoplasms
13
Recurrence
13
Advanced Cancer
13
Glioblastoma
12
Brain Neoplasms
12
Lymphoma
11
Kidney Neoplasms
11
Glioma
11
Prostatic Neoplasms
10
Lymphoma, Non-Hodgkin
10
Uveal Melanoma
9
Triple Negative Breast Neoplasms
9
Sarcoma
9
Interventions
Carboplatin
41
Paclitaxel
32
Radiotherapy
28
Cisplatin
25
Bevacizumab
24
Erlotinib Hydrochloride
19
Pemetrexed
18
Docetaxel
16
Gemcitabine
15
Gefitinib
8
Vinorelbine
7
Taxes
7
Cetuximab
7
ceritinib
5
Surgical Procedures, Operative
5
Etoposide
5
Amplified Fragment Length Polymorphism Analysis
5
sargramostim
3
pembrolizumab
3
capmatinib
3
Radiotherapy, Conformal
3
Radiation
3
Gene Expression Profiling
3
Cyclophosphamide
3
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a
3
trametinib
2
pegfilgrastim
2
osimertinib
2
Topotecan
2
Tirapazamine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Adenocarcinoma of Lung
×
Nivolumab
×
Clear all
NCT05081674
2023-10-11
BLISS
Hospital Israelita Albert Einstein
Phase 2
Completed
154 enrolled